Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BXC | XMTR |
|---|---|---|
| Price | $70.96 | $107.80 |
| Change today | ▼ 5.16% | ▼ 2.58% |
| Market cap | $557.76M | $6.18B |
| Return, 3 months | +37.0% | +15.1% |
| Return, year to date | +15.5% | +81.3% |
| Return, 1 year | -4.7% | +105.1% |
| P/E (TTM) | -308.5 | -179.7 |
| P/B | 0.9 | 10.4 |
| P/E percentile vs own 5y | 4th | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +4.4% | +41.1% |
| Net profit growth (YoY) | +48.6% | +79.9% |
| Gross margin | 15.8% | 38.7% |
| Operating margin | 1.2% | -3.8% |
| Net margin | -0.1% | -3.8% |
| Return on equity | -0.3% | -7.1% |
| Analyst target vs. price | +17.7% | +3.6% |
| Analyst buy share | 33% | 70% |
| RSI (14) | 41 | 62 |
| 30-day volatility | 54.0% | 55.3% |
| Max drawdown, 1 year | -42.6% | -49.9% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
